logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Medical Device
Filter

Medical Device

Categories

Sectors

Locations

Exchange

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

Commercial-Grade Replicel Injectors RepliCel in Production

Feb 3, 2020

Verastem Oncology 石药集团

Verastem Oncology Announces Dosing of First Patient in CSPC’s Chinese Study Evaluating COPIKTRA® (Duvelisib) in Patients with Relapsed or Refractory Follicular Lymphoma

Jan 31, 2020

Life Science

医疗保健精选——强生疫苗对决冠状病毒,Selecta Biosciences下跌5.17%

Healthcare Roundup – J&J enters coronavirus fray with planned vaccine, Selecta Biosciences -5.7%

Jan 29, 2020

Life Science

中美Oncologie开展胃癌精准医学计划

Genialis and Oncologie Collaborate on Precision Medicine Initiative in Gastric Cancer

Jan 23, 2020

Life Science

医疗保健精选—— 再鼎医药股票发行,礼来公司投资北卡罗来纳州工厂

Healthcare Roundup – Zai Lab launches equity offering, Lilly to invest $470M in North Carolina site

Jan 21, 2020

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Announces its Incoming Board of Directors

Dec 23, 2019

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Provides 2019 Year-End Update

Nov 26, 2019

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Life Sciences Announces Closing of Debt Settlement

Nov 4, 2019

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

Replicel Provides Update to Private Placement Financing of Preferred Shares

Oct 11, 2019

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

RepliCel Life 751,318 shares for debt

Oct 10, 2019

Life Science

Cellular Biomedicine 西比曼生物

CBMG Announces Plans to Build US R&D Facility for Immunotherapies

Oct 8, 2019

Life Science

Guanhao Biotech

Guanhao Bio Pays $3.1 Million to Acquire Stake in US-based ZY Therapeutics

Sep 26, 2019

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

Clinical Data Published from RepliCel’s Skin Rejuvenation Study

Sep 24, 2019

Life Science

Shanghai Pharmaceuticals

Shanghai Pharma Forms $250 Million China Antibody JV with Russia’s Biocad

Sep 18, 2019

Life Science

Replicel Life Sciences Inc TSXV:RP Biotechnology, Medical Device, Genomics, 生物科技,医疗设备,基因组学

Replicel Closes First Tranche of Private Placement Financing of Preferred Shares

Sep 13, 2019

Life Science

Genenta Science

Genenta Science of Milan Raises $14.6 Million in Funding Led by China Investor

Sep 13, 2019

Life Science

Henlius

Henlius Biotech Prices Hong Kong IPO to Raise $477 Million

Sep 12, 2019

Life Science

SoliPharma

SoliPharma of Hangzhou Raises $36.5 Million to Develop High End Generics

Sep 12, 2019

Life Science

  • ‹‹ Previous
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada